Li Mingli, Zhu Qiuying, Zheng Wenbin, Pan Peijiang, Liang Hao, Ye Li, Wang Xiaofang, Zhu Jinhui, Li Guojian, Dong Baiqing
1 School of Public Health, Guangxi Medical University , Nanning, Guangxi, China .
AIDS Res Hum Retroviruses. 2015 Apr;31(4):439-47. doi: 10.1089/AID.2014.0148. Epub 2015 Jan 6.
The purpose of this article is to describe mortality trends in different highly active antiretroviral therapy (HAART) periods and associated factors among AIDS patients in Guangxi, China. We prospectively analyzed AIDS patients in Guangxi between 2001 and 2011; demographic characteristics were compared among AIDS patients diagnosed in three treatment periods (pre-HAART: 2001-2004, early-HAART: 2005-2008, and late-HAART: 2009-2011). AIDS mortality was calculated by person-years, and treatment coverage was defined as the proportion of time that patients who were eligible for treatment received treatment. Factors of AIDS mortality were determined by a Cox proportional hazard regression. Of 19,020 AIDS patients, overall mortality declined from 41.1 per 100 person-years in 2001 to 13.3 per 100 person-years in 2011 with treatment coverage increasing from zero to 72.1%. The overall median survival figure was 5.6 years (95% CI: 4.4-6.8) with 60.3% for 5-year survival rate. After AIDS diagnosis, the mortality rate peaked in the first year, and 37.4% patients were still active in the ninth year. Protective factors for mortality were AIDS patients diagnosed from 2009 to 2011 (AHR=0.75, 95% CI: 0.58-0.89), having received HAART (AHR=0.71, 95% CI: 0.50-0.87), and having a CD4 count of higher than 350 cells/μl at AIDS diagnosis (AHR=0.79, 95% CI: 0.60-0.92). Risk factors for mortality included being male (AHR=1.28, 95% CI: 1.07-1.43), living in a rural area (AHR=1.40, 95% CI: 1.18-1.94), and being aged ≥60 years at AIDS diagnosis (AHR=1.36, 95% CI: 1.18-1.73). A decline in AIDS mortality was observed in Guangxi with a concomitant increase in treatment coverage. Some subpopulations of AIDS patients, such as males, rural residents, and the old, require more medical care.
本文旨在描述中国广西艾滋病患者在不同高效抗逆转录病毒治疗(HAART)时期的死亡率趋势及相关因素。我们对2001年至2011年广西的艾滋病患者进行了前瞻性分析;比较了在三个治疗时期(HAART前:2001 - 2004年,HAART早期:2005 - 2008年,以及HAART晚期:2009 - 2011年)确诊的艾滋病患者的人口统计学特征。艾滋病死亡率按人年计算,治疗覆盖率定义为符合治疗条件的患者接受治疗的时间比例。通过Cox比例风险回归确定艾滋病死亡率的相关因素。在19,020名艾滋病患者中,总体死亡率从2001年的每100人年41.1例降至2011年的每100人年13.3例,治疗覆盖率从零增至72.1%。总体中位生存时间为5.6年(95%置信区间:4.4 - 6.8),5年生存率为60.3%。艾滋病确诊后,死亡率在第一年达到峰值,37.4%的患者在第九年仍存活。死亡率的保护因素为2009年至2011年确诊的艾滋病患者(风险比=0.75,95%置信区间:0.58 - 0.89)、接受过HAART治疗(风险比=0.71,95%置信区间:0.50 - 0.87)以及艾滋病确诊时CD4细胞计数高于350个/μl(风险比=0.79,95%置信区间:0.60 - 0.92)。死亡率的风险因素包括男性(风险比=1.28,95%置信区间:1.07 - 1.43)、居住在农村地区(风险比=1.40,95%置信区间:1.18 - 1.94)以及艾滋病确诊时年龄≥60岁(风险比=1.36,95%置信区间:1.18 - 1.73)。广西艾滋病死亡率呈下降趋势,同时治疗覆盖率上升。部分艾滋病患者亚群体,如男性、农村居民和老年人,需要更多医疗护理。